2seventy bio, Inc.
TSVTDelisted May 13, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001860782
2seventy bio, Inc. was delisted on May 13, 2025; its insiders filed their last Form 4 on May 15, 2025; 140 institutions reported holding it in 13F filings for Q1 2025, worth $234.5M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 140
- Q1 2025, +25 vs. previous quarter
- 13F value
- $234.5M
- Reported value at the end of Q1 2025
- Superinvestors holding
- 0
- At the end of Q1 2025
Superinvestors holding TSVT, Q1 2025
No superinvestor reported holding TSVT at the end of Q1 2025.
Latest insider trades
Open-market purchases and sales by 2seventy bio, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2025 (view filing) | Mar 17 | 2 days | Snow JessicaChief Operating Officer | SSale | −2.30K | $4.95 | −$11.4K | −0.9%254.2K after | 10b5-1 |
| Mar 19, 2025 (view filing) | Mar 17 | 2 days | Baird William D IIIPresident and CEO | SSale | −5.09K | $4.95 | −$25.2K | −0.5%1.12M after | |
| Mar 19, 2025 (view filing) | Mar 17 | 2 days | Eatwell VictoriaChief Financial Officer | SSale | −2.59K | $4.95 | −$12.8K | −0.6%444.4K after | |
| Mar 13, 2025 (view filing)6:18 PM ET | Mar 11 | 2 days | Kynam Capital Management, LP and 4 others10% Owner | SSaleCommon Stock, par value $0.0001 per share | −11.1M | $4.93 | −$54.7M | −100.0%0 after | 2 lots |
| Mar 13, 2025 (view filing)6:18 PM ET | Mar 11 | 2 days | Kynam Capital Management, LP and 4 others10% Owner | SSaleCommon Stock, par value $0.0001 per share | −5.14M | $4.93 | −$25.4M | −100.0%0 after | |
| Jan 22, 2025 (view filing) | Jan 6 | 16 days | Snow JessicaSee Remarks | SSale | −1.84K | $2.79 | −$5.13K | −1.2%150.5K after | Amended10b5-1 |
| Jan 7, 2025 (view filing) | Jan 3-7 | 4 days | Snow JessicaSee Remarks | SSale | −6.19K | $2.81 | −$17.4K | −4.0%147.2K after | From original3 lots10b5-1 |
| Jan 7, 2025 (view filing) | Jan 3-6 | 4 days | Leschly NickDirector | SSale | −86.9K | $2.94 | −$255.3K | −6.6%1.23M after | 2 lots |
| Jan 7, 2025 (view filing) | Jan 3-6 | 4 days | Eatwell VictoriaChief Financial Officer | SSale | −1.11K | $2.93 | −$3.25K | −0.3%339.0K after | 2 lots |
| Jan 7, 2025 (view filing) | Jan 3-6 | 4 days | Baird William D IIIPresident and CEO | SSale | −32.5K | $2.94 | −$95.4K | −3.6%862.1K after | 2 lots |
Top 10 13F holders, Q1 2025
The largest institutional positions in 2seventy bio, Inc. at the end of Q1 2025; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Goldman Sachs Group Inc | 4,681,675 | $23.1M | 0.00% | +386,774+9.0% | Added |
| Beryl Capital Management LLC | 4,250,000 | $21.0M | 7.84% | +4,250,000 | New |
| BlackRock, Inc. | 3,971,873 | $19.6M | 0.00% | −250,781−5.9% | Reduced |
| Morgan Stanley | 2,967,078 | $14.7M | 0.00% | +49,194+1.7% | Added |
| Vanguard Group Inc | 2,819,469 | $13.9M | 0.00% | −941,776−25.0% | Reduced |
| Newtyn Management, LLC | 2,534,836 | $12.5M | 1.98% | 00.0% | Unchanged |
| Bank of America Corp | 2,516,505 | $12.4M | 0.00% | +6080.0% | Added |
| Baker Bros. Advisors LP | 2,497,526 | $12.3M | 0.14% | 00.0% | Unchanged |
| Man Group plc | 2,043,026 | $10.1M | 0.03% | +2,043,026 | New |
| Casdin Capital, LLC | 2,000,000 | $9.88M | 0.81% | 00.0% | Unchanged |